E. Bowton

发表

Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.

Melissa A. Basford, Raquel M. Zink, D. Roden, 2012, Pharmacogenomics.

Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action

Hua Xu, Peilin Jia, Zhongming Zhao, 2015, PLoS Comput. Biol..

Biobanks and Electronic Medical Records: Enabling Cost-Effective Research

D. Roden, J. Denny, J. Schildcrout, 2014, Science Translational Medicine.

Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project

E. Clayton, J. Schildcrout, J. Peterson, 2012, Clinical pharmacology and therapeutics.

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data

Melissa A. Basford, Raquel M. Zink, J. Haines, 2013, Nature Biotechnology.

A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program.

Joshua C Denny, Dan M Roden, Melissa A. Basford, 2016, Journal of clinical epidemiology.

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.

Melissa A. Basford, M. Loh, M. Relling, 2015, Blood.

Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT

J. Rothman, J. Javitch, E. Bowton, 2011, Nature Neuroscience.

Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record

D. Roden, J. Schildcrout, M. Ritchie, 2012, Clinical pharmacology and therapeutics.

Electronic health record design and implementation for pharmacogenomics: a local perspective

Kevin B. Johnson, Dan M. Roden, Jill M. Pulley, 2013, Genetics in Medicine.

Using systems approaches to address challenges for clinical implementation of pharmacogenomics

Joshua C Denny, Dan M Roden, Josh F Peterson, 2014, Wiley interdisciplinary reviews. Systems biology and medicine.

Ethical and practical challenges to studying patients who opt out of large-scale biorepository research.

S. T. Rosenbloom, E. Clayton, B. Malin, 2013, Journal of the American Medical Informatics Association : JAMIA.

Stakeholder engagement: a key component of integrating genomic information into electronic health records

Erica A. Bowton, Andrea Hartzler, Kadija Ferryman, 2013, Genetics in Medicine.

A genome-wide association study of heparin-induced thrombocyto - penia using an electronic medical record

D. Roden, J. Denny, A. Teumer, 2014, Thrombosis and Haemostasis.

PheWAS Network Analysis and Visualization

Joshua C. Denny, Shyr Yu, Eric Torstenson, 2015, AMIA.

ADHD-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation

M. Gill, R. Blakely, J. Veenstra-VanderWeele, 2012 .

Genotype and risk of major bleeding during warfarin treatment.

B. Gage, D. Roden, J. Denny, 2014, Pharmacogenomics.

Calmodulin Kinase II Interacts with the Dopamine Transporter C Terminus to Regulate Amphetamine-Induced Reverse Transport

H. Sitte, J. Javitch, R. Colbran, 2006, Neuron.

SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking

J. Sutcliffe, H. Coon, R. Blakely, 2014, Translational Psychiatry.

Phenotype-Driven Plasma Biobanking Strategies and Methods

Nancy J. Brown, Daniel C. Liebler, Erica A. Bowton, 2015, Journal of personalized medicine.

Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Nicole A. Restrepo, Melissa A. Basford, Niloufar B. Gillani, 2013, Pharmacogenomics.

A Juxtamembrane Mutation in the N Terminus of the Dopamine Transporter Induces Preference for an Inward-Facing Conformation

R. Neubig, H. Weinstein, Lei Shi, 2009, Molecular Pharmacology.

Anomalous Dopamine Release Associated with a Human Dopamine Transporter Coding Variant

R. Blakely, H. Sitte, E. Bowton, 2008, The Journal of Neuroscience.

Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux

J. Javitch, R. Colbran, E. Bowton, 2008, Molecular Pharmacology.

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing

Erica A. Bowton, Dan M. Roden, Jonathan S. Schildcrout, 2013, Clinical pharmacology and therapeutics.

Corrigendum: Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT

J. Rothman, J. Javitch, E. Bowton, 2011 .

Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults

D. Roden, J. Denny, Ziding Feng, 2017, Pharmacogenetics and genomics.

Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

Melissa A. Basford, J M Pulley, D M Roden, 2012, Clinical pharmacology and therapeutics.

Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy

Dana C. Crawford, Erica A. Bowton, Dan M. Roden, 2015, PloS one.

Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation

Michael Gill, Erica Bowton, Randy D Blakely, 2012, The Journal of Neuroscience.

Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder

R. Blakely, M. Caron, J. Javitch, 2010, The Journal of Neuroscience.

Genetic determinants of variability in warfarin response after the dose-titration phase

D. Roden, J. Denny, J. Schildcrout, 2016, Pharmacogenetics and genomics.

A Study of Transportability of an Existing Smoking Status Detection Module across Institutions

Hongfang Liu, Qingxia Chen, Hua Xu, 2012, AMIA.

Examining Rare and Low-Frequency Genetic Variants Previously Associated With Lone or Familial Forms of Atrial Fibrillation in an Electronic Medical Record System: A Cautionary Note

D. Roden, J. Denny, C. Shaffer, 2014, Circulation. Cardiovascular genetics.

Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin

Hua Xu, Marylyn D. Ritchie, Joshua C. Denny, 2011, J. Am. Medical Informatics Assoc..

Inclusion of Pediatric Samples in an Opt‐Out Biorepository Linking DNA to De‐Identified Medical Records: Pediatric BioVU

D M Roden, D. Roden, E. Bowton, 2013, Clinical pharmacology and therapeutics.

Examining Rare and Low-Frequency Genetic Variants Previously Associated With Lone or Familial Forms of Atrial Fibrillation in an Electronic Medical Record System: A Cautionary Note

D. Roden, J. Denny, E. Bowton, 2015, Circulation: Cardiovascular Genetics.

Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project

E. Clayton, J. Schildcrout, J. Peterson, 2012, Clinical pharmacology and therapeutics.

Abstract 19509: Identifying Genotype-Phenotype Relations in Electronic Medical Record Systems: Application to Warfarin Pharmacogenomics.

Marylyn D. Ritchie, Joshua C. Denny, Dana C. Crawford, 2010 .

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real‐World Implementation

Kristin A. Maloney, R. Altman, M. Relling, 2013, Clinical pharmacology and therapeutics.

Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record

Melissa A. Basford, Raquel M. Zink, D. Roden, 2012, Clinical pharmacology and therapeutics.